FDA Inspection 1276700 — Implant Direct Sybron Manufacturing LLC
The FDA completed an inspection of Implant Direct Sybron Manufacturing LLC on Jul 24, 2025 in Westlake Village, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Westlake Village, CA (United States)